FDA Issues Recall Alert for Hypoallergenic Infant Formula

January 2, 2024 by Dan McCue
FDA Issues Recall Alert for Hypoallergenic Infant Formula

WASHINGTON — A popular hypoallergenic infant formula has been voluntarily recalled by its manufacturer due to possible Cronobacter sakazakii contamination.

The formula, Nutramigen Hypoallergenic Infant Formula Powder, is manufactured by Reckitt/Mead Johnson Nutrition.

According to an alert issued by the U.S. Food and Drug Administration on Sunday, the agency learned of the possible contamination of the product, which is used by infants with allergies to cow’s milk, from the Israeli Ministry of Health on Dec. 14.

The ministry told U.S. regulators that a contaminated sample was discovered during routine sampling of imported products at the Israeli border. It identified the sampled formula as having been produced at Mead Johnson Nutrition’s Zeeland, Michigan, facility.

The FDA says the notice led to a full scale investigation that included genome sequencing on the sample obtained from the infant formula to confirm the initial findings of Cronobacter species and to determine whether the isolate was Cronobacter sakazakii. 

Cronobacter sakazakii is a pathogen found naturally in the environment that can enter manufacturing facilities and home environments on hands, shoes and other contaminated surfaces. 

While infant formula firms are required to test a representative sample of their product for both Cronobacter and Salmonella species, this verification step does not guarantee the product is free of Cronobacter. 

Cronobacter contamination can occur at very low levels and is not evenly distributed throughout the product, making it difficult to detect. Powdered infant formula is not a sterile product and public health agencies, including the FDA, routinely encourage caregivers to take steps to prepare powdered infant formula as safely as possible. 

The FDA said Sunday that no illnesses have been reported in connection with the recall, and it is likely that most of the formula distributed in the United States has already been consumed.

Consumers who have Nutramigen Hypoallergenic Infant Formula Powder with the batch codes below are advised to stop using it and throw it away or contact Reckitt/Mead Johnson Nutrition for a refund:

  • ZL3FHG (12.6 oz cans).
  • ZL3FMH (12.6 oz cans).
  • ZL3FPE (12.6 oz cans).
  • ZL3FQD (12.6 oz cans).
  • ZL3FRW (19.8 oz cans).
  • ZL3FXJ (12.6 oz cans).

The products have a UPC Code of 300871239418 or 300871239456 and “Use By Date” of Jan. 1, 2025.

The FDA said though Nutramigen is a specialty infant formula, there are substitute infant formulas available. 

The agency further advises that if the infant formula a child uses is unavailable, parents and caregivers should work with their child’s health care provider to find a suitable substitute.

The FDA does not expect that this recall will have a major impact on the U.S. supply and availability of powdered infant formulas.

While the FDA’s inspection is ongoing, all testing conducted to date by the FDA and Reckitt/Mead Johnson Nutrition has been negative for Cronobacter.

The company, meanwhile, has initiated a voluntary recall of 675,030 cans of Nutramigen Powdered Infant Formula distributed to the United States.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • baby formula recall
  • FDA
  • Nutramigen Hypoallergenic Infant Formula powder
  • In The News

    Health

    Voting

    Health

    The Older Americans Act Is Not Keeping Pace With Today’s Older Adults

    In 1965, the Older Americans Act was a beacon of successful bipartisan legislation to address the social, economic and health needs... Read More

    In 1965, the Older Americans Act was a beacon of successful bipartisan legislation to address the social, economic and health needs of older Americans on a national level. Nearly 60 years later, the act has changed little, yet life for older adults and what it takes for them... Read More

    May 13, 2024
    by Beth McCue
    Finnish Study Finds Link Between Premature Menopause and Mortality Risk

    OULU, Finland — A study by researchers at University of Oulu and Oulu University Hospital in Finland found women who enter... Read More

    OULU, Finland — A study by researchers at University of Oulu and Oulu University Hospital in Finland found women who enter menopause before the age of 40 are more likely to die young, but may lower their risk with hormone therapy. The researchers presented their findings at... Read More

    May 13, 2024
    by Jesse Zucker
    Alcohol-Free May Become the New Normal

    WASHINGTON — People have consumed alcohol in some form since the beginning of human history, dating back to ancient civilizations... Read More

    WASHINGTON — People have consumed alcohol in some form since the beginning of human history, dating back to ancient civilizations in Egypt, India, China, Greece and Rome. While drinking alcohol in moderation can be enjoyable, excessive use can be harmful to your health and many suffer... Read More

    May 13, 2024
    by Jesse Zucker
    Combining Aerobic and Strength Exercise Improves Heart Health

    WASHINGTON — Setting a goal to start exercising to improve your heart health is a great plan for everyone, regardless... Read More

    WASHINGTON — Setting a goal to start exercising to improve your heart health is a great plan for everyone, regardless of age, gender, or health status. The two main types of exercise are aerobic (or cardio) and resistance (or strength). The CDC and WHO suggest how... Read More

    Illness Took Away Her Voice. AI Created a Replica She Carries in Her Phone

    PROVIDENCE, R.I. (AP) — The voice Alexis “Lexi” Bogan had before last summer was exuberant. She loved to belt out... Read More

    PROVIDENCE, R.I. (AP) — The voice Alexis “Lexi” Bogan had before last summer was exuberant. She loved to belt out Taylor Swift and Zach Bryan ballads in the car. She laughed all the time — even while corralling misbehaving preschoolers or debating politics with friends over... Read More

    May 8, 2024
    by Dan McCue
    House Panel Throws Unanimous Support Behind Telehealth Bill

    WASHINGTON — The House Ways and Means Committee unanimously advanced a bill on Wednesday that would extend Medicare’s COVID-era ability... Read More

    WASHINGTON — The House Ways and Means Committee unanimously advanced a bill on Wednesday that would extend Medicare’s COVID-era ability to support telehealth visits and pay for acute-level hospital care provided in patients’ homes. The proposed legislation, called the Preserving Telehealth, Hospital and Ambulance Access Act,... Read More

    News From The Well
    scroll top